Entrar/Registro  
INICIO ENGLISH
 
MediSan
   
MENÚ

Contenido por año, Vol. y Num.

Índice de este artículo

Información General

Instrucciones para Autores

Mensajes al Editor

Directorio






>Revistas >MediSan >Año 2012, No. 04


Reyes SIS, Venzant MM, García CME, Miró RJ
Tratamiento de pacientes inmunocompetentes con neumonía adquirida en la comunidad
MediSan 2012; 16 (04)

Idioma: Español
Referencias bibliográficas: 44
Paginas: 581-595
Archivo PDF: 220.64 Kb.


Texto completo




RESUMEN

Se hizo una revisión bibliográfica actualizada sobre el tratamiento de pacientes con neumonía adquirida en la comunidad. Se consideraron las medidas terapéuticas generales y la administración de medicamentos según 4 grupos de estratificación: primero, los afectados tratados ambulatoriamente, sin historia de enfermedad cardiopulmonar, factores modificadores o uso reciente de antibióticos; segundo, aquellos con terapia ambulatoria y antecedentes de enfermedad cardiopulmonar o factores modificadores (o ambos) o aplicación reciente de antimicrobianos; tercero, personas hospitalizadas en salas convencionales; y cuarto, los individuos ingresados en la Unidad de Cuidados Intensivos (con riesgo de infección por Pseudomonas aeruginosa o sin este). Asimismo, se ofrecen criterios y recomendaciones sobre el alta hospitalaria de estos pacientes.


Palabras clave: neumonía extrahospitalaria, paciente inmunocompetente, Pseudomonas aeruginosa, tipos de terapias, atención secundaria de salud.


REFERENCIAS

  1. Ross JS, Normand SL, Wang Y, Ko DT, Chen J, Drye EE, et al. Hospital volume and 30-day mortality for three common medical conditions. N Engl J Med. 2010;362(12):1110-8.

  2. Pneumonia. En: Harrinson TR. Principios de medicina interna. 16 ed. México DF: McGraw-Hill Interamericana, 2006.

  3. Ruhnke GW, Coca-Perraillon M, Kitch BT, Cutler DM. Trends in mortality and medical spending in patients hospitalized for community-acquired pneumonia: 1993-2005. Med Care. 2010;48(12):1111-6.

  4. Álvarez Gutiérrez FA, García Fernández A, Elías Hernández T, Romero Contreras J, Romero Romero B, Castillo Gómez J. Neumonías adquiridas en la comunidad en pacientes mayores de 60 años. Incidencia de gérmenes atípicos y evolución clinicorradiológica. Med Clin (Barc). 2001;117(12):441-5.

  5. Ramos A, Asensio A, Caballos D, José Mariño M. Factores pronósticos de la neumonía por aspiración adquirida en la comunidad. Med Clin Bar. 2002;119(3):81-4.

  6. Cuba. Ministerio de Salud Pública. Anuario Estadístico del 2010. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2011.

  7. Marrie TJ, Shariatzadeh MR. Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study. Medicine (Baltimore). 2007;86(2):103-11.

  8. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):27-72.

  9. Van der Eerden MM, Vlaspolder F, de Graaff CS, Groot T, Bronsveld W, Jansen HM, et al. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study. Thorax. 2005;60(8):672-8.

  10. Kanwar M, Brar N, Khatib R, Fakih MG. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest. 2007;131(6):1865-9.

  11. Wachter RM, Flanders SA, Fee C, Pronovost PJ. Public reporting of antibiotic timing in patients with pneumonia: lessons from a flawed performance measure. Ann Intern Med. 2008;149(1):29-32.

  12. Fee C, Weber EJ. Identification of 90% of patients ultimately diagnosed with community-acquired pneumonia within four hours of emergency department arrival may not be feasible. Ann Emerg Med. 2007;49(5):553-9.

  13. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Jeune IL, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl 3):1-55.

  14. Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, et al. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007;175(10):1086-93.

  15. Robenshtock E, Shefet D, Gafter-Gvili A, Paul M, Vidal L, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Library. 2010 [citado 15 marzo 2011];(10). Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004418.pub3/pdf

  16. Waterer GW, Kessler LA, Wunderink RG. Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia. Chest. 2006;130(1):11-5.

  17. Metersky ML, Sweeney TA, Getzow MB, Siddiqui F, Nsa W, Bratzler DW, et al. Antibiotic timing and diagnostic uncertainty in Medicare patients with pneumonia: is it reasonable to expect all patients to receive antibiotics within 4 hours? Chest. 2006; 130(1):16-21.

  18. Welker JA, Huston M, McCue JD. Antibiotic timing and errors in diagnosing pneumonia. Arch Intern Med. 2008;168(4):351-6.

  19. File TM, Gross PA. Performance measurement in community-acquired pneumonia: consequences intended and unintended. Clin Infect Dis. 2007;44(7):942-4.

  20. Niederman MS. Recent advances in community-acquired pneumonia: inpatient and outpatient. Chest. 2007;131(4):1205-15.

  21. Mitka M. JCAHO tweaks emergency departments' pneumonia treatment standards. JAMA. 2007;297(16):1758-9.

  22. Rubinstein E, Kollef MH, Nathwani D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46(Suppl 5):378-85.

  23. Metersky ML, Ma A, Houck PM, Bratzler DW. Antibiotics for bacteremic pneumonia: Improved outcomes with macrolides but not fluoroquinolones. Chest. 2007;131(2):466-73.

  24. Restrepo MI, Mortensen EM, Waterer GW, Wunderink RG, Coalson JJ, Anzueto A. Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia. Eur Respir J. 2009;33(1):153-9.

  25. Martin Loeches I, Lisboa T, Rodriguez A, Putensen C, Annane D, Garnacho-Montero J, et al. Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensive Care Med. 2010;36(4):612-20.

  26. Stevens DL, Ma Y, Salmi DB, McIndoo E, Wallace RJ, Bryant AE. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis. 2007;195(2):202-11.

  27. Kallen AJ, Brunkard J, Moore Z, Budge P, Arnold KE, Fosheim G, et al. Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med. 2009;53(3):358-65.

  28. Olive D, Georges H, Devos P, Boussekey N, Chiche A, Meybeck A, et al. Severe pneumococcal pneumonia: impact of new quinolones on prognosis. BMC Infect Dis. 2011;11:66.

  29. Ho PL, Chin-Chung Cheng V, Chu CM. Antibiotic resistance in community-acquired pneumonia caused by Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, and Acinetobacter baumannii. Chest. 2009;136:1119-27.

  30. American Thoracic Society. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR. 2005;54(12):1169–227.

  31. Nathan RV, Rhew DC, Murray C, Bratzler DW, Houck PM, Weingarten SR. In-hospital observation after antibiotic switch in pneumonia: a national evaluation. Am J Med. 2006;119(6):512-7.

  32. Fine MJ, Stone RA, Singer DE, Coley CM, Marrie TJ, Lave JR, et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med. 1999;159(9):970-80.

  33. Menéndez R, Torres A, Zalacaín R, Aspa J, Martín Villasclaras JJ, Borderías L, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax. 2004;59:960-5.

  34. Rosón B, Carratalà J, Fernández-Sabé N, Tubau F, Manresa F, Gudiol F. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch Intern Med. 2004;164(5):502-8.

  35. Dagan E, Novack V, Porath A. Adverse outcomes in patients with community acquired pneumonia discharged with clinical instability from Internal Medicine Department. Scand J Infect Dis. 2006;38(10):860-6.

  36. Li JZ, Winston LG, Moore DH, Bent S. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis. Am J Med. 2007;120(9):783.

  37. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163(7):1730-54.

  38. Bartlett JG, Dowell SF, Mandell LA, File TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis. 2000;31(2):347-82.

  39. Bruns AHW, Oosterheert JJ, Prokop M, Lammers JW, Hak Ee, Hoepelman AI. Patterns of resolution of chest radiograph abnormalities in adults hospitalized with severe community-acquired pneumonia. Clin Infect Dis. 2007;45(8):983-91.

  40. El Solh AA, Aquilina AT, Gunen H, Ramadan F. Radiographic resolution of community-acquired bacterial pneumonia in the elderly. J Am Geriatr Soc. 2004;52(2):224-9.

  41. Bruns AH, Oosterheert JJ, El Moussaoui R, Opmeer BC, Hoepelman AI, Prins JM. Pneumonia recovery: discrepancies in perspectives of the radiologist, physician and patient. J Gen Intern Med. 2010;25(3):203-6.

  42. Jasti H, Mortensen EM, Obrosky DS, Kapoor WN, Fine MJ. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Clin Infect Dis. 2008;46(4):550-6.

  43. Capelastegui A, España Yandiola PP, Quintana JM, Bilbao A, Diez R, Pascual S, et al. Predictors of short-term rehospitalization following discharge of patients hospitalized with community-acquired pneumonia. Chest. 2009;136(4):1079-85.

  44. Genné D, Sommer R, Kaiser L, Saaidia A, Pasche A, Anger PF, et al. Analysis of factors that contribute to treatment failure in patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis. 2006;25(3):159-66.



>Revistas >MediSan >Año2012, No. 04
 

· Indice de Publicaciones 
· ligas de Interes 






       
Derechos Resevados 2019